Gaurang Shah of Geojit Financial Services told CNBC-TV18, "Since the time Dr Lal PathLabs got listed there has not been much of a great performance after the initial run-up. In the healthcare segment in case if the investor wants to make a switch would prefer Apollo Hospitals with a long-term point of view. As a disclosure we do have a positive coverage on Apollo Hospitals."
At 14:45 hrs Apollo Hospitals Enterprises was quoting at Rs 1,179.35, up Rs 18.05, or 1.55 percent.
The share touched its 52-week high Rs 1,356.75 and 52-week low Rs 959.00 on 12 June, 2017 and 14 November, 2017, respectively.
Currently, it is trading 13.08 percent below its 52-week high and 22.98 percent above its 52-week low.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!